Reuters logo
BRIEF-WSE admits to trade Celon Pharma shares as of Oct. 17
October 13, 2016 / 10:26 AM / a year ago

BRIEF-WSE admits to trade Celon Pharma shares as of Oct. 17

Oct 13 (Reuters) - Warsaw Stock Exchange (WSE):

* Drug producer, Celon Pharma’s IPO-CEL.WA, 15 million series B shares will be admitted to trade on the WSE main market as of Oct. 17

* Celon Pharma’s shares to be traded under short name CLNPHARMA-PDA and ticker CLNA Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below